can tirzepatide cause heart issues Associated with Lower Risk of and Kidney Damage Compared to Dulaglutide in Patients with Type 2 Diabetes and Cardiovascular Disease Effects of tirzepatide on circulatory

When fat cells shrink, they release hormones differently, and this can lead to lighter, heavier, shorter, or longer periods

Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes

Visual fields showed a mildly enlarged blind spot in each eye ( Figure 2 )

New indication strategies are most powerful when they expand a drug into a much larger patient population or when the new indication is clinically significant enough to justify premium pricing that erodes more slowly than the original indications market